IS7078A - Mycoplasma bovis bóluefni og aðferðir til að minnka lungnabólgu í dýrum - Google Patents

Mycoplasma bovis bóluefni og aðferðir til að minnka lungnabólgu í dýrum

Info

Publication number
IS7078A
IS7078A IS7078A IS7078A IS7078A IS 7078 A IS7078 A IS 7078A IS 7078 A IS7078 A IS 7078A IS 7078 A IS7078 A IS 7078A IS 7078 A IS7078 A IS 7078A
Authority
IS
Iceland
Prior art keywords
animals
methods
mycoplasma bovis
bovis vaccines
pneumonia
Prior art date
Application number
IS7078A
Other languages
English (en)
Icelandic (is)
Inventor
Lee Keich Robin
Ross Mcgavin David
John Yancey Robert
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS7078A publication Critical patent/IS7078A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IS7078A 2001-07-02 2003-12-15 Mycoplasma bovis bóluefni og aðferðir til að minnka lungnabólgu í dýrum IS7078A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02
PCT/IB2002/002514 WO2003004052A1 (en) 2001-07-02 2002-06-27 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals

Publications (1)

Publication Number Publication Date
IS7078A true IS7078A (is) 2003-12-15

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7078A IS7078A (is) 2001-07-02 2003-12-15 Mycoplasma bovis bóluefni og aðferðir til að minnka lungnabólgu í dýrum

Country Status (31)

Country Link
US (1) US20030147914A1 (enExample)
EP (1) EP1401488A1 (enExample)
JP (1) JP2004536106A (enExample)
KR (1) KR20040030783A (enExample)
CN (1) CN1522152A (enExample)
AP (1) AP2002002568A0 (enExample)
AR (1) AR036125A1 (enExample)
BG (1) BG108496A (enExample)
BR (1) BR0210798A (enExample)
CA (1) CA2452580A1 (enExample)
CZ (1) CZ20033465A3 (enExample)
EA (1) EA200301324A1 (enExample)
GT (1) GT200200139A (enExample)
HN (1) HN2002000162A (enExample)
HR (1) HRP20031078A2 (enExample)
HU (1) HUP0501188A2 (enExample)
IL (1) IL159516A0 (enExample)
IS (1) IS7078A (enExample)
MA (1) MA27048A1 (enExample)
MX (1) MXPA03011815A (enExample)
NO (1) NO20035767L (enExample)
OA (1) OA12640A (enExample)
PA (1) PA8549801A1 (enExample)
PE (1) PE20030239A1 (enExample)
PL (1) PL373891A1 (enExample)
SK (1) SK15802003A3 (enExample)
TN (1) TNSN03154A1 (enExample)
UY (1) UY27365A1 (enExample)
WO (1) WO2003004052A1 (enExample)
YU (1) YU102103A (enExample)
ZA (1) ZA200309747B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
UA98115C2 (ru) 2006-09-11 2012-04-25 Пфайзер Продактс Инк. Композиция, которая содержит подвергнутые тепловой обработке бактерины
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
EP2320943B1 (en) * 2008-07-03 2016-02-17 Iowa State University Research Foundation, Inc. Cattle vaccines
SG10201506597RA (en) * 2008-10-31 2015-10-29 Boehringer Ingelheim Vetmed Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2010140377A1 (ja) 2009-06-04 2010-12-09 独立行政法人産業技術総合研究所 マイコプラズマ感染症用ワクチン
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
DK3334454T3 (da) 2015-08-14 2022-11-14 Zoetis Services Llc Mycoplasma-Bovis-sammensætninger
AU2016380864B2 (en) 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
EP1401488A1 (en) 2004-03-31
AR036125A1 (es) 2004-08-11
WO2003004052A1 (en) 2003-01-16
JP2004536106A (ja) 2004-12-02
ZA200309747B (en) 2005-05-27
CN1522152A (zh) 2004-08-18
YU102103A (sh) 2006-05-25
CZ20033465A3 (cs) 2004-12-15
KR20040030783A (ko) 2004-04-09
BG108496A (en) 2005-02-28
PE20030239A1 (es) 2003-03-21
GT200200139A (es) 2003-02-13
PA8549801A1 (es) 2003-09-17
IL159516A0 (en) 2004-06-01
CA2452580A1 (en) 2003-01-16
OA12640A (en) 2006-06-15
TNSN03154A1 (fr) 2005-12-23
UY27365A1 (es) 2003-04-30
EA200301324A1 (ru) 2004-12-30
HRP20031078A2 (en) 2005-08-31
NO20035767L (no) 2004-01-30
MA27048A1 (fr) 2004-12-20
SK15802003A3 (sk) 2005-01-03
AP2002002568A0 (en) 2002-06-30
HN2002000162A (es) 2002-09-17
MXPA03011815A (es) 2004-04-02
US20030147914A1 (en) 2003-08-07
PL373891A1 (en) 2005-09-19
HUP0501188A2 (en) 2006-05-29
BR0210798A (pt) 2006-05-23

Similar Documents

Publication Publication Date Title
NO20035767L (no) Mycyplasma Bovis vaksine og fremgangsmater for redusering av pneumonia i dyr
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
IS7672A (is) Bóluefni gegn öldrunar- og æxlunarkerfa sýkingum í nautgripum
DK1651401T3 (da) Partikelformigt trækonserveringsmiddel og fremgangsmåde til fremstilling deraf
NO20044915L (no) C-aryl-glukosid SGLT2 inhibitorer og metode
NO2015008I2 (no) olaparib og salter derav
DK1211350T5 (da) Individuelt beskyttet kordel, dens anvendelse i bygningsværker og fremgangsmåde til dens fremstilling
DK1294237T3 (da) Hidtil ukendt selskabsdyrefodersammensætning og fremgangsmåde
EP1549135A4 (en) VACCINE COMPOSITIONS AND AUXILIARY
IS7726A (is) Pyrazólólpyridín og aðferðir til þess að búa þau til og nota
IS8329A (is) Kínólínafleiður og notkun þeirra í meðferð
DK1716234T3 (da) Substitueret, ikke-kodende nukleinsyremolekyle til terapeutisk og profylaktisk immunstimulering i mennesker og højerestående dyr
DK1267899T3 (da) ssa-inaktiverede salmonellavacciner
FI20030855A0 (fi) Tietueitten käsittely vastinparien löytämiseksi referenssitietojoukoista
NO20041058L (no) Preparater og fremgangsmater relatert til nye benzodiazepinforbindelser og mal derav
NO20053593D0 (no) Arylalkylkarbamat-derivater, fremgangsmate og anvendelse derav i terapi
PL1601744T3 (pl) Urządzenie do gazyfikacji i sposób gazyfikacji
IS8090A (is) Samsetning til að bæta vitsmuni og minni
DK2116257T3 (da) Parenterale vaccineformuleringer og anvendelser deraf
IS7417A (is) Ambroxól til að meðhöndla kvalafullt ástand í munni og koki
ITMI20012021A0 (it) Dispositivo per movimentare pezzi da lavorare e7o lavorati
NO20031378L (no) Gjengivelsesmetode, gjengivelsesanordning, registreringsmetode og registreringsanordning
IS6870A (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og notkun þeirra í meðferð
DE60104616D1 (de) Videokodierungsverfahren und -vorrichtung
DK1406895T3 (da) Lactonformuleringer og fremgangsmåde til anvendelse deraf